Andson Biotech
Empowering Mass Spec for Biotech and Beyond
Atlanta, United States · Founded 2021 · $8.3M raised
- Headquarters
- Atlanta, Georgia
- Employees
- 1–10
- Founded
- 2021
- Website
- andsonbiotech.com
- Total Funding
- $8.3M
- Last Round
- $4.7M Series AOct 2025
- Rounds
- 2
About
Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control.
Summary
Andson Biotech is a Biotech company based in Atlanta, United States, founded in 2021. It has raised $8.3M in total across 2 rounds, most recently a $4.7M Series A round in Oct 2025. Investors include Unpopular Ventures, Gaingels and Phase Two Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...